Authored by Prof Tate, Katie Peppercorn, Nick Bowden, Fiona Charlton
This article discusses several complex chronic conditions characterised by persistent fatigue and overlapping symptoms, including Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long COVID, Fibromyalgia, Ehlers-Danlos syndromes, and Multiple Sclerosis. Although these conditions are distinct, they share physiological features—such as immune dysfunction, neurological imbalance, metabolic and energy production abnormalities, and disruptions in the gut-immune-brain axis—that can lead to misdiagnosis and diagnostic difficulty. Two frequently comorbid disorders, Postural Orthostatic Tachycardia Syndrome (POTS) and Mast Cell Activation Syndrome (MCAS), are also described due to their close pathophysiological links with the chronic fatigue states.
The review highlights that effective treatments remain limited, and patients often face barriers in healthcare access, prolonged isolation from employment, and restricted social support. Current public health systems and policies are insufficient to meet patient needs, leading to significant quality-of-life impacts.
The authors argue for more integrated research and shared knowledge across these conditions to improve understanding, expand common therapeutic options, and shape coordinated health policies. There may be significant advantages for patients if collective knowledge was shared and integrated, with more co-ordinated health policies to support patients. They suggest that the comparatively well-structured care model for Multiple Sclerosis could serve as an example for managing other chronic fatigue conditions.
Reference
TATE, Warren et al. Managing chronic fatigue conditions with overlapping symptoms, and the health policies and social services supporting those affected. Medical Research Archives, [S.l.], v. 13, n. 11, dec. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/7104>. doi: https://doi.org/10.18103/mra.v13i11.7104.